What are the benefits of using volatile halogenated anesthetics and opioids during myocardial ischemia?
Volatile halogenated anesthetics and opioids have anti-ischemic or conditioning properties, and have been shown to reduce troponin release, preserve myocardial function, and improve resource utilization such as ICU or hospital lengths of stay, and 1-year outcome.